Transmolecular Awarded Phase II Sbir Grant

TransMolecular, Inc.TransMolecular, Inc. has received a Phase II Small Business Innovation Research (SBIR) grant to discover and develop pharmaceutical alternatives for treating neuropathic pain.

The grant is worth approximately $760,000 over the next two years.

“Neuropathic or chronic pain represents an underserved medical need. Ion channels have played an important part in the development of many potent blockbuster drugs. Our work is unique because the company has focused a major amount of its research effort into the development of a specific sodium ion channel that is only expressed in pain signaling nerve tissue,” said Matthew A. Gonda, Ph.D., president and CEO of TransMolecular.

He added, “These particular ion channels are of great interest to the pharmaceutical industry because they provide a new molecular target for discovering drugs to modulate the abnormal firing of neuronal impulses. This research will lead to the development of a new generation of pain control agents for which the potential market is very large. Funding of our grant validates the importance of our research into this ion channel as a new drug target.”

TransMolecular has exclusively licensed from Yale University a new sodium ion channel mined from the central nervous system (CNS) that produces abnormal repetitive neuronal firing, an underlying cause of neuropathic pain.

Ion channels are involved in more than 30 different disorders, several of which affect the CNS. Researchers at TransMolecular are developing targets for discovering new drug therapies for chronic or neuropathic pain resulting from arthritis, diabetes, cancer and back disorders-based on the identification of a new sodium ion channel as a major target in the pain pathway.

TransMolecular, Inc., founded in 1996, is a privately held neuroscience biotechnology company committed to discovering, developing and commercializing novel and proprietary products to diagnose and treat disorders and diseases of the central nervous system having inadequate pharmaceutical alternatives, including cancer and pain.

Best Steroids

Dragon Pharma is a pharmacy company specializing in anabolic steroids: Sustanon 350.

Obtain Dragon Pharmaceutical Ready for Use

TriTren 150 - Cheap Price

Administration: Injection
Primary Chemical Name: Tri Trenbolone
Made by: Dragon Pharmaceutical
Unit: 20 x 10 mL vial (150 mg/mL)
Price: 20 x $65.00

Clomid - Cheap Price

Administration: Oral
Active Constituent: Clomiphene Citrate
Producer: Dragon Pharma LLC
Unit: 20 x 100 pastilles (50 mg/pill)
Price: 20 x $58.00

Masteron 200 - Bulk Price

Administration: Injection
Main Substance: Drostanolone Enanthate
Made by: Dragon Pharmaceuticals
Package: 10 x 10 mL vial (200 mg/mL)
Price: 10 x $67.00

EQ 300 - Cheap Price

Administration: Injection
Principal Ingredient: Boldenone Undecylenate
Made by: Dragon Pharmaceuticals
Pack: 20 x 10 mL vial (300 mg/mL)
Price: 20 x $35.00

Trenbolone 100 - Cheap Price

Administration: Injection
Primary Chemical Name: Trenbolone Acetate
Made by: Dragon Pharma LLC
Amount: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $52.00

Trenbolone 200

Injectable Anabolic Steroid
Basic Component: Trenbolone Enanthate
Made by: Dragon Pharmaceutical
Pack: 1 X 10 ml (200 mg/ml)

Enanthat 250 [10 Vials]

Injectable Steroid for Muscle Growth
Primary Substance: Testosterone Enanthate
Made by: Dragon Pharma Labs
10 Vials [10 mL per Vial (250 mg/ml)]
Price: 10 x $36.00 = $360.00 in Total

Propionat 100 [10 Vials]

Injectable Steroid for Muscle Growth
Basal Component: Testosterone Propionate
Manufacturer: Dragon Pharma LLC
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $30.00 = $300.00 in Total

Clenbuterol

Prime Ingredient: Clenbuterol Hydrochloride
Produced by: Dragon Pharma LLC
Pack: 100 tablets (40 mcg/pastille)

Trenbolone 200

Principal Ingredient: Trenbolone Enanthate
Made by: Dragon Pharma Labs
Pack: 10 x 10 mL vial (200 mg/mL)

EQ 500

Basal Chemical Name: Boldenone Undecylenate
Made by: Dragon Pharma Labs
Pack: 10 mL vial (500 mg/mL)

Cut Mix 150

Main Ingredient: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Branded by: Dragon Pharmaceuticals
Amount: 10 x 10 mL vial (150 mg/mL)